|
Median (range)
|
---|
Age
|
66 (52–74)
|
Preoperative serum PSA (ng/ml)
|
10.3 (0.2-118.0)
|
|
% (n)
|
Preoperative serum PSA
| |
<10 ng/ml
|
41.7 (35)
|
≥10 ng/ml
|
58.3 (49)
|
Gleason score
| |
<7
|
28.6 (24)
|
7
|
47.6 (40)
|
>7
|
23.8 (20)
|
Clinical T stage
| |
I
|
56 (47)
|
II
|
44 (37)
|
Pathological T stage
| |
II
|
64.3 (54)
|
III
|
32.1 (27)
|
IV
|
3.6 (3)
|
Node involvement
|
7.1 (6)
|
Positive surgical margins
|
41.7 (35)
|
Perineural invasion
|
17.9 (15)
|
Total Biochemical progression
|
40.5 (34)
|
at 5 years
|
38.1 (32)
|
5 - 10 years
|
2.4 (2)
|
Survival
|
64.7a(22)
|
Deaths
|
35.3a(12)
|
- aExpressed respect total biochemical progressión